Prague Med. Rep. 2019, 120, 39-51
https://doi.org/10.14712/23362936.2019.9
Lipoprotein(a) – Link between Atherogenesis and Thrombosis
Crossref Cited-by Linking
- El Beayni Nancy, Szanto Timea, Neerman-Arbez Marguerite, Casini Alessandro, Lassila Riitta: Highly thrombogenic phenotype and impaired wound healing in a patient with congenital dysfibrinogenemia: case report. Research and Practice in Thrombosis and Haemostasis 2024, 8, 102469. <https://doi.org/10.1016/j.rpth.2024.102469>
- 郭 明燕: Study on the Correlation between Lipoprotein a and Coronary Heart Disease in Young- and Middle-Aged People. ACM 2024, 14, 2054. <https://doi.org/10.12677/acm.2024.1451650>
- Tsioulos Georgios, Kounatidis Dimitris, Vallianou Natalia G., Poulaki Aikaterini, Kotsi Evangelia, Christodoulatos Gerasimos Socrates, Tsilingiris Dimitrios, Karampela Irene, Skourtis Alexandros, Dalamaga Maria: Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?. IJMS 2024, 25, 3537. <https://doi.org/10.3390/ijms25063537>
- 郝 贝贝: Lipoprotein (a): A Potential New Target for Acute ST-Segment Elevation Myocardial Infarction. ACM 2023, 13, 18890. <https://doi.org/10.12677/ACM.2023.13122657>
- 李 霜: Influence of Immune and Inflammatory Effects on the Pathogenesis of Coronary Artery Disease. ACM 2023, 13, 2898. <https://doi.org/10.12677/ACM.2023.133410>
- Emelyanchik V. S., Nikulina S. Yu., Emelyanchik E. Yu., Protopopov A. V.: New opportunities for identifying the risk of cardiovascular events in young people: the role of familial hypercholesterolemia. Russ J Cardiol 2023, 27, 5294. <https://doi.org/10.15829/1560-4071-2022-5294>
- Artemenkov Aleksey A.: Plasma dyslipidemia: pathogenesis and diagnostic value. Literature review. Perm Medical Journal 2023, 40, 78. <https://doi.org/10.17816/pmj40178-93>
- Maryanto Sugeng, Oktianti Dian: Apo-B Levels and Abdominal Aortic Wall Thickness in Hypercholesterolemic Rats Treated with Red Guava Fruit. AMNT 2023, 7, 112. <https://doi.org/10.20473/amnt.v7i1.2023.112-119>
- Lampsas Stamatios, Xenou Maria, Oikonomou Evangelos, Pantelidis Panteleimon, Lysandrou Antonios, Sarantos Savvas, Goliopoulou Athina, Kalogeras Konstantinos, Tsigkou Vasiliki, Kalpis Athanasios, Paschou Stavroula A., Theofilis Panagiotis, Vavuranakis Manolis, Tousoulis Dimitris, Siasos Gerasimos: Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment. Molecules 2023, 28, 969. <https://doi.org/10.3390/molecules28030969>
- Ding Wern Yew, Protty Majd B, Davies Ian G, Lip Gregory Y H: Relationship between lipoproteins, thrombosis, and atrial fibrillation. Cardiovascular Research 2022, 118, 716. <https://doi.org/10.1093/cvr/cvab017>
- DeFilippis Andrew P, Trainor Patrick J, Thanassoulis George, Brumback Lyndia C, Post Wendy S, Tsai Michael Y, Tsimikas Sotirios: Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis. European Heart Journal 2022, 43, 971. <https://doi.org/10.1093/eurheartj/ehab600>
- Fedorowski Artur, Siller-Matula Jolanta M, Patti Giuseppe: Thrombosis and fibrinolysis in atherosclerotic cardiovascular disease: it takes two to tango. European Heart Journal 2022, 43, 982. <https://doi.org/10.1093/eurheartj/ehab710>
- Telyuk Pyotr, Austin David, Luvai Ahai, Zaman Azfar: Lipoprotein(a): Insights for the Practicing Clinician. JCM 2022, 11, 3673. <https://doi.org/10.3390/jcm11133673>
- Morris Gerwyn, Berk Michael, Walder Ken, O’Neil Adrienne, Maes Michael, Puri Basant K.: The lipid paradox in neuroprogressive disorders: Causes and consequences. Neuroscience & Biobehavioral Reviews 2021, 128, 35. <https://doi.org/10.1016/j.neubiorev.2021.06.017>
- Ugovšek Sabina, Šebeštjen Miran: Lipoprotein(a)—The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation. Biomolecules 2021, 12, 26. <https://doi.org/10.3390/biom12010026>
- 姬 赞赞: Correlation between Lipoprotein A and Prognosis of Acute Coronary Syndrome. ACM 2020, 10, 2799. <https://doi.org/10.12677/ACM.2020.1011425>
